• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idenix Pharmaceuticals Inc

+ Add to Watchlist


5.4600 USD 0.0400 0.73%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Idenix Pharmaceuticals Inc (IDIX)

Open: 5.4600 Day's Range: 5.3000 - 5.6800 Volume: 710,276
Previous Close: 5.5000 52wk Range: 2.9301 - 9.3200 1-Yr Rtn: +46.38%

Stock Chart for IDIX

No chart data available.
  • IDIX:US 5.4600
  • 1D
  • 1M
  • 1Y
Interactive IDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IDIX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8863
Est. EPS (USD) (12/2014) -0.8100
Est. PEG Ratio -
Market Cap (M USD) 823.39
Shares Outstanding (M) 150.80
30 Day Average Volume 1,521,944
Price/Book (mrq) 6.9086
Price/Sale (ttm) 1,558.5787
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IDIX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IDIX

Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

Ronald C Renaud Jr "Ron"President/CEODouglas MayersExec VP/Chief Medical Officer
Jacques DumasExec VP/Chief Scientific OfcrDaniella BeckmanSenior VP/CFO/Treasurer
More Company Profile & Key Executives for IDIX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil